{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:04:46Z","timestamp":1791734686107,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05019-y","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:17:10Z","timestamp":1776676630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["First, do no trend: aligning parenteral lipid therapy with physiology and evidence in neonates"],"prefix":"10.1038","author":[{"given":"Parvesh Mohan","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Bolisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilia R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-9354","authenticated-orcid":false,"given":"Muralidhar H.","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"5019_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/archdischild-2020-319108","volume":"106","author":"LC Frazer","year":"2021","unstructured":"Frazer, L. C. & Martin, C. R. Parenteral lipid emulsions in the preterm infant: current issues and controversies. Arch. Dis. Child Fetal Neonatal Ed. 106, 676\u2013681 (2021).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"5019_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.plefa.2011.10.012","volume":"86","author":"RS Kuipers","year":"2012","unstructured":"Kuipers, R. S. et al. Fetal intrauterine whole body linoleic, arachidonic and docosahexaenoic acid contents and accretion rates. Prostaglandins Leukot. Ess. Fat. Acids 86, 13\u201320 (2012).","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"5019_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jpeds.2011.04.039","volume":"159","author":"CR Martin","year":"2011","unstructured":"Martin, C. R. et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J. Pediatr. 159, 743\u2013749.e1\u20132 (2011).","journal-title":"J. Pediatr."},{"key":"5019_CR4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0022-2275(20)41397-5","volume":"33","author":"D Rubin","year":"1992","unstructured":"Rubin, D. & Laposata, M. Cellular interactions between n-6 and n-3 fatty acids: a mass analysis of fatty acid elongation\/desaturation, distribution among complex lipids, and conversion to eicosanoids. J. Lipid Res. 33, 1431\u20131440 (1992).","journal-title":"J. Lipid Res."},{"key":"5019_CR5","first-page":"300","volume":"14","author":"AA Leaf","year":"1992","unstructured":"Leaf, A. A., Leighfield, M. J., Costeloe, K. L. & Crawford, M. A. Factors affecting long-chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants. J. Pediatr. Gastroenterol. Nutr. 14, 300\u2013308 (1992).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"5019_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpeds.2012.06.045","volume":"162","author":"DT Robinson","year":"2013","unstructured":"Robinson, D. T. et al. Docosahexaenoic and arachidonic acid levels in extremely low birth weight infants with prolonged exposure to intravenous lipids. J. Pediatr. 162, 56\u201361 (2013).","journal-title":"J. Pediatr."},{"key":"5019_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jpen.2422","volume":"47","author":"KA Huff","year":"2023","unstructured":"Huff, K. A. et al. Patterns of lipid-injectable emulsion use in neonatal intensive care units across the United States: a multi-institution survey. JPEN J. Parenter. Enter. Nutr. 47, 51\u201358 (2023).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"5019_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12887-020-1958-9","volume":"20","author":"S Bolisetty","year":"2020","unstructured":"Bolisetty, S. et al. Standardised neonatal parenteral nutrition formulations\u2014Australasian neonatal parenteral nutrition consensus update 2017. BMC Pediatr. 20, 59 (2020).","journal-title":"BMC Pediatr."},{"key":"5019_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jpen.1432","volume":"43","author":"N Memon","year":"2019","unstructured":"Memon, N., Hussein, K., Hegyi, T., Herdt, A. & Griffin, I. J. Essential Fatty Acid Deficiency with SMOFlipid Reduction in an Infant with Intestinal Failure-Associated Liver Disease. JPEN J. Parenter. Enter. Nutr. 43, 438\u2013441 (2019).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"5019_CR10","first-page":"1","volume":"85","author":"T He","year":"2024","unstructured":"He, T., Huang, J., Ren, D. & Yang, S. Impact of SMOFlipid on clinical outcomes in neonates receiving parenteral nutrition: a systematic review and meta-analysis of randomized controlled trials. Br. J. Hosp. Med. 85, 1\u201320 (2024).","journal-title":"Br. J. Hosp. Med."},{"key":"5019_CR11","first-page":"CD013171","volume":"6","author":"V Kapoor","year":"2019","unstructured":"Kapoor, V., Malviya, M. N. & Soll, R. Lipid emulsions for parenterally fed term and late preterm infants. Cochrane Database Syst. Rev. 6, CD013171 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"5019_CR12","first-page":"CD013163","volume":"6","author":"V Kapoor","year":"2019","unstructured":"Kapoor, V., Malviya, M. N. & Soll, R. Lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst. Rev. 6, CD013163 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"5019_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2019.102026","volume":"156","author":"H Suganuma","year":"2020","unstructured":"Suganuma, H. et al. Intravenous fat induces changes in PUFA and their bioactive metabolites: Comparison between Japanese and Australian preterm infants. Prostaglandins Leukot. Ess. Fat. Acids 156, 102026 (2020).","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"5019_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","volume":"20","author":"S Najm","year":"2017","unstructured":"Najm, S. et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial. Clin. Nutr. ESPEN 20, 17\u201323 (2017).","journal-title":"Clin. Nutr. ESPEN"},{"key":"5019_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/MPG.0000000000000174","volume":"58","author":"G Deshpande","year":"2014","unstructured":"Deshpande, G. et al. Fish Oil (SMOFlipid) and olive oil lipid (Clinoleic) in very preterm neonates. J. Pediatr. Gastroenterol. Nutr. 58, 177\u2013182 (2014).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"5019_CR16","doi-asserted-by":"publisher","first-page":"9177","DOI":"10.1039\/D0FO01462A","volume":"11","author":"L Kutzner","year":"2020","unstructured":"Kutzner, L. et al. Effect of dietary EPA and DHA on murine blood and liver fatty acid profile and liver oxylipin pattern depending on high and low dietary n6-PUFA. Food Funct. 11, 9177\u20139191 (2020).","journal-title":"Food Funct."},{"key":"5019_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/jpen.1153","volume":"42","author":"J-C Lavoie","year":"2018","unstructured":"Lavoie, J.-C., Mohamed, I., Nuyt, A.-M., Elremaly, W. & Rouleau, T. Impact of SMOFLipid on pulmonary alveolar development in newborn guinea pigs. JPEN J. Parenter. Enter. Nutr. 42, 1314\u20131321 (2018).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"5019_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJMoa1611942","volume":"376","author":"CT Collins","year":"2017","unstructured":"Collins, C. T. et al. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. N. Engl. J. Med 376, 1245\u20131255 (2017).","journal-title":"N. Engl. J. Med"},{"key":"5019_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamaophthalmol.2017.6658","volume":"136","author":"CA L\u00f6fqvist","year":"2018","unstructured":"L\u00f6fqvist, C. A. et al. Association of retinopathy of prematurity with low levels of arachidonic acid: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 136, 271\u2013277 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"5019_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2020.8896","volume":"324","author":"I Marc","year":"2020","unstructured":"Marc, I. et al. Effect of maternal docosahexaenoic acid supplementation on bronchopulmonary dysplasia-free survival in breastfed preterm infants: a randomized clinical trial. JAMA 324, 157\u2013167 (2020).","journal-title":"JAMA"},{"key":"5019_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3945\/an.113.004671","volume":"5","author":"MH Premkumar","year":"2014","unstructured":"Premkumar, M. H., Carter, B. A., Hawthorne, K. M., King, K. & Abrams, S. A. Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience. Adv. Nutr. 5, 65\u201370 (2014).","journal-title":"Adv. Nutr."},{"key":"5019_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jpeds.2020.09.068","volume":"230","author":"KM Gura","year":"2021","unstructured":"Gura, K. M., Premkumar, M. H., Calkins, K. L. & Puder, M. Fish oil emulsion reduces liver injury and liver transplantation in children with intestinal failure-associated liver disease: a multicenter integrated study. J. Pediatr. 230, 46\u201354.e2 (2021).","journal-title":"J. Pediatr."},{"key":"5019_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tjnut.2024.10.047","volume":"155","author":"E Lucchinetti","year":"2025","unstructured":"Lucchinetti, E. et al. The Novel Lipid emulsion vegaven is well tolerated and elicits distinct biological actions compared with a mixed-oil lipid emulsion containing fish oil: a parenteral nutrition trial in piglets. J. Nutr. 155, 703\u2013718 (2025).","journal-title":"J. Nutr."},{"key":"5019_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jpen.2088","volume":"46","author":"G Guthrie","year":"2022","unstructured":"Guthrie, G. et al. Depletion and enrichment of phytosterols in soybean oil lipid emulsions directly associate with serum markers of cholestasis in preterm parenteral nutrition-fed pigs. JPEN J. Parenter. Enter. Nutr. 46, 160\u2013171 (2022).","journal-title":"JPEN J. Parenter. Enter. Nutr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05019-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:17:12Z","timestamp":1776676632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05019-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":24,"alternative-id":["5019"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05019-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Martin C.R.: Scientific Advisory Board: Plakous Therapeutics, LactaLogics; Vitara Biomedical, Alcresta Therapeutics, Kamada Pharmaceuticals; Consulting\/Speaking Honorarium: Baxter International; Research Grant: Mead Johnson Nutrition; Nutrition Expert Testimony: Winston & Strawn, LLP\/Abbott Nutrition.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}